-
COVID treatment Molnupiravir approved for import in China
2023-01-04
China's top drug regulator said on Friday that it has granted conditional market approval for the import of Merck's COVID-19 treatment, Molnupiravir.
-
Mr Xu Jinghe Attends the “CIMDR - GHWP Session & International Drug Regulatory Authorities Dialogue”
2022-12-28
On the evening of December 20, 2022, the "China International Medical Device Regulatory Forum (CIMDR) - Global Harmonization Working Party (GHWP) Session & International Drug Regulatory Authorities Dialogue" was held online. Mr Xu Jinghe, Deputy Commissioner of the National Medical Products Administration (NMPA), attended the meeting online and delivered keynote speech.
-
China has 13 COVID vaccines available for second booster
2022-12-27
A total of 13 types of COVID-19 vaccines, approved for conditional marketing or emergency use, are now available as a second booster dose in China, according to experts with the State Council inter-agency task force for COVID-19 response.
-
China producing 60 million COVID-19 antigen test kits daily
2022-12-23
China's daily output of antigen test kits has hit around 60 million units, as the country steps up output of anti-COVID-19 medical supplies.
-
Chinese mainland reports 3,049 new local confirmed COVID-19 cases
2022-12-21
The Chinese mainland on Tuesday reported 3,049 locally transmitted confirmed COVID-19 cases, the National Health Commission said Wednesday.
-
Chinese mainland reports 2,656 new local confirmed COVID-19 cases
2022-12-20
The Chinese mainland on Monday reported 2,656 locally transmitted confirmed COVID-19 cases, the National Health Commission said Tuesday.
